Form 4 for LUNG Pulmonx Corp
Accepted 2025-03-05 00:00:00 ET · period of report 2025-03-03 · accession 0001415889-25-007042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-05 | 2025-03-03 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +181.7K | 376.0K | +93% | $0 |
| D | 2025-03-05 | 2025-03-03 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | S - Sale | $7.14 | -27.7K | 194.3K | -12% | -$197.7K |
| D | 2025-03-05 | 2025-03-03 | LUNG | Williamson Steven S. | Pres AND CEO, Dir | A - Grant | $0.00 | +128.4K | 128.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-03 | A | A | 181,696 | $0.00 | 376,038 | D | — | — | (F3) Represents grant of RSUs payable solely in common stock of the Issuer that vest in equal quarterly installments over the four-year period from the grant date of March 3, 2025. |
| 2 | Common | Common Stock | 2025-03-03 | S | D | 27,689 | $7.14 | 194,342 | D | — | — | (F2) Includes 2,500 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 21, 2025. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-03-03 | A | A | 128,395 | $0.00 | 128,395 | D | $8.29 · — to 2035-03-02 | 128,395 Common Stock | (F4) The shares subject to the option vest in 48 equal monthly installments from the grant date on March 3, 2025. |